Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period

View through CrossRef
Abstract Aim Evaluation the levels of markers having highest prediction value regarding the risk of death in patients with STEMI and NSTEMI in 1 year after angioplasty. Material and methods The study enrolled 558 patients with STEMI and 553 pts with NSTEMI. From those who dead and survived 4 groups of pts have been selected by equal number 75 and homogenous concerning gender, age, comorbidities, cardiovascular risk factors and time of culprit coronary artery (s) revascularization. 62 markers referring to inflammation, endothelial and hemostasis dysfunction, NETosis, neuroendocrine activity and oxidative stress, cell injury and cardiovascular remodeling have been determined at admission (before coronary angioplasty) and at 24th hour after. Prediction power of markers regarding death risk was estimated by Odd’s ratio. Results Mortality rate was 17,03% (95 pts) in STEMI, and 14,8% (82 pts) in NSTEMI. In concern to Odd’s ratio having highest and similar power of death prediction should be emphasized following 9 markers determined at admission: IL-1β, selectin-E, endocan, von Willebrand/ADAMTS13 ratio, platelets microvesicles (CD62P), neutrophil elastase, myeloperoxidase, Ang 1-7/Ang II ratio and GDF-15. The Odd’s ratio of these markers was in a range of 2.26-2.97 (CI p<0,001). Remarkable, that in dead pts only have been found circulating activator autoantibodies against receptor ETA of ET-1 in 21 pts of STEMI (22.1%) and 16 pts of NSTEMI (19.5%). Noteworthy, in the top of reperfusion outrage on myocardium (first 24 hours) the increment of ischemia modified albumin (IMA) and H-FABP was significantly higher in dead vs survivors. More than that, the increasing ratio of these markers was higher in NSTEMI vs STEMI: 88.5 and 104.8% vs 65.5 and 85.2%, what in principle confirms the Heusch’s hypothesis viewing ischemic precondition influence on myocardial damage inherent to reperfusion impact. Conclusion Our study underlined at admission 9 circulating markers demonstrating a highest and similar Odd’s ratio of death risk in pts with either STEMI of NSTEMI which conceptually could be linked to key mechanisms of coronary microcirculatory dysfunction. Likewise, the increment of IMA and H-FABP from admission to 24 hours may reliably predict risk of death, and its higher level in NSTEMI indicates a more considerable contribution of reperfusion impact on myocardial damage in comparison with STEMI.
Title: Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period
Description:
Abstract Aim Evaluation the levels of markers having highest prediction value regarding the risk of death in patients with STEMI and NSTEMI in 1 year after angioplasty.
Material and methods The study enrolled 558 patients with STEMI and 553 pts with NSTEMI.
From those who dead and survived 4 groups of pts have been selected by equal number 75 and homogenous concerning gender, age, comorbidities, cardiovascular risk factors and time of culprit coronary artery (s) revascularization.
62 markers referring to inflammation, endothelial and hemostasis dysfunction, NETosis, neuroendocrine activity and oxidative stress, cell injury and cardiovascular remodeling have been determined at admission (before coronary angioplasty) and at 24th hour after.
Prediction power of markers regarding death risk was estimated by Odd’s ratio.
Results Mortality rate was 17,03% (95 pts) in STEMI, and 14,8% (82 pts) in NSTEMI.
In concern to Odd’s ratio having highest and similar power of death prediction should be emphasized following 9 markers determined at admission: IL-1β, selectin-E, endocan, von Willebrand/ADAMTS13 ratio, platelets microvesicles (CD62P), neutrophil elastase, myeloperoxidase, Ang 1-7/Ang II ratio and GDF-15.
The Odd’s ratio of these markers was in a range of 2.
26-2.
97 (CI p<0,001).
Remarkable, that in dead pts only have been found circulating activator autoantibodies against receptor ETA of ET-1 in 21 pts of STEMI (22.
1%) and 16 pts of NSTEMI (19.
5%).
Noteworthy, in the top of reperfusion outrage on myocardium (first 24 hours) the increment of ischemia modified albumin (IMA) and H-FABP was significantly higher in dead vs survivors.
More than that, the increasing ratio of these markers was higher in NSTEMI vs STEMI: 88.
5 and 104.
8% vs 65.
5 and 85.
2%, what in principle confirms the Heusch’s hypothesis viewing ischemic precondition influence on myocardial damage inherent to reperfusion impact.
Conclusion Our study underlined at admission 9 circulating markers demonstrating a highest and similar Odd’s ratio of death risk in pts with either STEMI of NSTEMI which conceptually could be linked to key mechanisms of coronary microcirculatory dysfunction.
Likewise, the increment of IMA and H-FABP from admission to 24 hours may reliably predict risk of death, and its higher level in NSTEMI indicates a more considerable contribution of reperfusion impact on myocardial damage in comparison with STEMI.

Related Results

Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Introduction: Acute myocardial infarction remains a leading cause of cardiovascular mortality worldwide [1 ]. However, ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) pati...
Arrythmic storm in patients with and without a myocardial infarction
Arrythmic storm in patients with and without a myocardial infarction
Abstract Introduction Available data on arrhythmic storm (AS) is frequently obtained from retrospective observational series of ...
Subfatin concentration decreases in acute coronary syndrome
Subfatin concentration decreases in acute coronary syndrome
We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NST...
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Introduction: Serum troponin is a ubiquitous biomarker used to diagnose acute myocardial infarction (AMI). The positive predictive value (PPV) of high-sensitivity tropo...
Abstract 4147967: Increased Mortality Risk in Masquerading STEMI Presentations Compared with True STEMI Patients
Abstract 4147967: Increased Mortality Risk in Masquerading STEMI Presentations Compared with True STEMI Patients
Background: Prehospital identification of STEMI reduces time to reperfusion by timely primary PCI or fibrinolytic therapy. We previously reported that 40-50% of prehosp...

Back to Top